Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2010 | 03-2010 | 12-2009 | 09-2009 | 06-2009 | |
| Sales | 4 | 5 | 2,039 | 4 | 31 |
| Gross Profit | 4 | 5 | 2,039 | 4 | 31 |
| Operating Expenses | 4,722 | 5,438 | 3,872 | 2,764 | 3,807 |
| Operating Income | -4,718 | -5,433 | -1,833 | -2,760 | -3,776 |
| Other Income | 378 | 4,661 | -437 | -3,185 | -2,556 |
| Pre-tax Income | -4,340 | -772 | -2,270 | -5,945 | -6,332 |
| Net Income Continuous | -4,340 | -772 | -2,470 | -5,945 | -6,332 |
| Net Income | $-4,340 | $-772 | $-2,470 | $-5,945 | $-6,332 |
| EPS Basic Total Ops | -1.02 | -0.18 | -0.54 | -1.44 | -1.80 |
| EPS Basic Continuous Ops | -1.01 | -0.18 | -0.53 | -1.44 | -1.81 |
| EPS Diluted Total Ops | -1.02 | -0.18 | -0.54 | -1.44 | -1.80 |
| EPS Diluted Continuous Ops | -1.01 | -0.18 | -0.53 | -1.44 | -1.81 |
| EBITDA(a) | $-4,597 | $-5,321 | $-1,763 | $-2,693 | $-3,709 |